chevrons

Back to Previous Page

Company Quarterly Earnings Update – QNS VN – 2020 H1

Summary of the 2020 H1 results of Quang Ngai Sugar JSC (QNS VN)

H1/2020 results highlights:
  • Overall, QNS’s sale reached VND3,249bn, -20.2% y/y. Soymilk sales declined by 6.0% y/y as the COVID-19 affected consumers’ spending. Sugar’s sale declined by 49.3% y/y due to unfavorable weather, which also curbed the country’s output by 34.5%. Also, the sale Refine-Extra (RE) sugar will only start from H2. Therefore, QNS’s net profit was 1,092bn, -15.4%, while its margin was up by 70bps, to 13.5%.
  • In June, QNS started exporting to China, with two products, i.e. original flavor, and less sugary flavor, via supermarkets and e-commerce websites like JD or Tmall.
  • QNS’s financial position remained solid. Cash and made up 27% of total assets. Leverage was moderate with a D/E and a D/A of 0.27x and 0.19x respectively).
Outlook
  • Vietnam has contained the COVID-19 outbreak very effectively, with minimal social distancing measures needed. As the COVID-19 situation will be soon under control, we think the consumption of soymilk will recover in H2. Whereas its long-term growth driver is still the gradual switch to branded products. For sugar, RE sale will start in H2/2020 to tap into the country’s shortage. For biomass, thanks to the new price, QNS will start using other input materials. We revised down 2020 revenue and profit forecast by 15.1% and 11.7% respectively to account for lower expected earnings, caused by the second outbreak. For 2021, we keep our last forecast, as the business will normalize and benefit from the above long-term trend.
  • For 2020, we estimate the QNS’s revenue to amount to VND7,428bn, -3.3% y/y, and its bottom line will decline by 16.7% y/y, reaching VND1,075bn.
  • For 2021, we estimate QNS’s revenue and net profit will recover strongly by 36.0% y/y and 26.8%, respectively. Its net margin will slightly reduce to 13.5%.
Recommendation

Company ratings and target prices are accessible for clients only.

If you are interested in getting full access to our paid Primary Research Materials feel free to get in touch with us at your convenience.

Our team is actively covering 50 companies in the listed Vietnamese equity space for our clients.


Featured image credit: soha.vn

Related News & Insights
Find out more navigation_button
news

Summary of 9M 2025 results and outlook of Nam Long Investment (NLG VN) The real estate market saw a rebound in new supply, supported by government initiatives that accelerated project development and sales launches. However, this recovery remains insufficient to narrow the supply-demand gap, as new launches are still concentrated in high-end and luxury segments. […]

Read Newsarrow
news

Summary of 9M 2025 results and outlook of Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD VN) Net revenue rose 8.5% y/y to VND1,355bn, driven by self-produced product sales, which accounted for 98.1% of total revenue. In Hospital channel: Revenue increased by 11.7% y/y to VND891bn, led by strong sales of key products including oncology […]

Read Newsarrow
news

Summary of 9M 2025 results and outlook of Hau Giang Pharmaceutical JSC (DHG VN) Net revenue grew 7.0% to VND3,524bn. In pharmacy channel (84.9% of total sales), early in the year, new tax and invoicing regulations posed challenges for traditional pharmacies, DHG’s main clients. It swiftly implemented support programs—including e-invoicing software assistance, promotional initiatives, and […]

Read Newsarrow
Find out more navigation_button